- Source of Wealth: Biotechnology
- Age: 54
- Nationality: English
- Date of Birth: May 1965
- Occupation: Co-Founder and Deputy Chairman of Abcam plc
- Education: Leicester University, University of Bath
Working as a research fellow at Cambridge University, he identified the market opportunity in supplying high-quality antibodies to support protein interaction studies. Abcam supplies more than 45,000 antibodies that track proteins in the human genome project to 50 laboratories worldwide. It floated on AIM in 2005. Profits rose 58.4% in 2009-10, pushing the shares to record levels. Abcam is worth about £690m and Milner has a £93m stake. Share sales add £12m.